Skip to content

R&D at other companies

Stryker logo
StrykerSYK
$413M+2.0%
Solventum logo
SolventumSOLV
$189M-2.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$103.4M-6.5%
Medtronic logo
MedtronicMDT
$671M-1.9%
Intuitive Surgical logo
Intuitive SurgicalISRG
$361.9M+14.5%

Segments

By segment

See full
Reportable Segment$25.54M+15.9%

Other financials

Income statement

See full
Revenue$182.3M+47.2%
Gross profit$154.2M+53.9%
Operating income$32.1M+144%
Net income$35.1M+105%
EPS (diluted)$0.41-68.7%

Balance sheet

See full
Cash & equivalents$188.1M-35.2%
Total debt$7.0M
Total equity$111.7M+136%
Total assets$728.8M

Cash flow

See full
Operating cash flow$43.1M+775%
CapEx$83.0K+62.7%
Free cash flow$43.0M+782%

Valuation

See full
Market cap$5.37B

Profitability

See full
Gross margin80.8%+1.5pp
Operating margin-85.8%
Net margin-83.9%
FCF margin32.3%

Returns & leverage

See full
Debt / equity0.1×
Current ratio1.3×

Where this comes from

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about HNGE's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HNGE's R&D?
HNGE (HNGE) reported R&D of $30.34M in Q1 2026.
How has HNGE's R&D changed year-over-year?
HNGE's R&D increased by 29.1% year-over-year, from $23.5M to $30.34M.
What is the long-term trend for HNGE's R&D?
Over 2 years (2023 to 2025), HNGE's R&D has grown at a 82.9% compound annual growth rate (CAGR), from $110.06M to $368.14M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.